Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Normative modeling for quantitative brain MRI phenotyping and biomarker discovery for pediatric leukodystrophies.

medRxiv : the preprint server for health sciences·2026
Same author

Impaired lipoprotein secretion by APOE4 leads to lysosomal and mitochondrial dysfunction in human microglia.

bioRxiv : the preprint server for biology·2026
Same author

Microglia replacement by ER-Hoxb8 conditionally immortalized macrophages provides insight into Aicardi-Goutières syndrome neuropathology.

eLife·2026
Same author

Targeting DNA-LNPs to Endothelial Cells Improves Expression Magnitude, Duration, and Specificity.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

CaMPARI2 Enables Stimulus-Locked Whole-Brain Activity Mapping at Cellular Resolution in Unrestrained Larval Zebrafish.

bioRxiv : the preprint server for biology·2026
Same author

Dynamic changes in mitochondria support phenotypic flexibility of microglia.

Nature communications·2025

Related Experiment Video

Updated: Aug 15, 2025

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
05:35

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

3.0K

Engineering an inhibitor-resistant human CSF1R variant for microglia replacement.

Jean Paul Chadarevian1,2,3, Sonia I Lombroso4,5,6, Graham C Peet4,7

  • 1Department of Neurobiology & Behavior, University of California, Irvine , Irvine, CA, USA.

The Journal of Experimental Medicine
|December 30, 2022
PubMed
Summary

Researchers engineered a modified CSF1R (G795A) to enable safe microglia replacement via transplantation. This breakthrough offers a promising, less toxic alternative to current methods for brain cell therapy.

More Related Videos

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
06:12

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Published on: September 6, 2024

1.4K
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.9K

Related Experiment Videos

Last Updated: Aug 15, 2025

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
05:35

Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route

Published on: May 31, 2022

3.0K
Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
06:12

Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders

Published on: September 6, 2024

1.4K
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
07:54

Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility

Published on: April 13, 2017

9.9K

Area of Science:

  • Neuroscience
  • Immunology
  • Stem Cell Biology

Background:

  • Hematopoietic stem cell transplantation (HSCT) can replace brain microglia but carries high mortality risks.
  • Existing methods for microglia replacement are limited by toxicity and efficacy.

Purpose of the Study:

  • To engineer a novel, inhibitor-resistant colony-stimulating factor 1 receptor (CSF1R) for enhanced microglia replacement.
  • To develop a safer and more effective method for replacing endogenous microglia.

Main Methods:

  • Engineered a glycine to alanine substitution at position 795 (G795A) in human CSF1R to confer resistance to CSF1R inhibitors.
  • Utilized CRISPR technology to engineer human induced pluripotent stem cell-derived microglia (iMG) with the G795A variant.
  • Performed xenotransplantation studies in mice to assess engraftment, persistence, and replacement capacity of engineered microglia.

Main Results:

  • The G795A mutation confers resistance to CSF1R inhibitors (PLX3397, PLX5622) without altering receptor function.
  • G795A-expressing macrophages efficiently engraft and persist in the mouse brain during inhibitor treatment.
  • Engineered G795A-iMG successfully replaced endogenous microglia in a xenotransplantation model, demonstrating functional and gene expression similarity to wildtype iMG.

Conclusions:

  • The engineered G795A CSF1R variant enables robust and specific microglia replacement.
  • This approach offers a potentially safer and more effective cell-based therapy for neurological conditions requiring microglia modulation.